PRSS1 p.Arg116Pro
c.347G>C · rs199769221 · VCV161986
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0969 | likely benign ⚠ discordant with ClinVar |
|---|---|---|
| REVEL | 0.36 | indeterminate |
| SaProt | LLR -3.68 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | Δ0.26 | acceptor gain · deltas |
| Constraint at this position | ||
| Conservation | phyloP 0.23 | GERP -0.11 |
| Regional constraint | o/e 1.20 | unconstrained · MANE · 3,532 bp · p 0.00039 · regional, not allelic |
| Overall | ||
| CADD | 1.396 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Amishnot grpmax-eligible | 0.119% | 840 |
| African / African-Americangrpmax | 0.032% | 3,128 |
| Ashkenazi Jewishnot grpmax-eligible | 0.00715% | 13,989 |
| Remaining individualsnot grpmax-eligible | 0.0067% | 14,935 |
| Admixed American | 0.00367% | 27,218 |
| European (non-Finnish) | 0.00215% | 46,501 |
| Finnishnot grpmax-eligible | 0.00166% | 60,152 |
| South Asian | 0.00113% | 88,534 |
Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PRSS1
- Protein
- p.Arg116Pro
- Coding
- c.347G>C
- MANE Select
- NM_002769
- dbSNP
- rs199769221
- Type
- single nucleotide variant
- Location
- chr7:142751920 (GRCh38)
- Gene constraint
- LOEUF 1.301 · pLI <0.01 · ClinGen HI 0/3 (gnomAD)
- Structure
- AlphaFold pLDDT 92.24 · 12 PDB
- Residue 116
- a UniProt-annotated variant site (in pctt); an α-helix; the peptidase s1 domain
Disease context
hereditary chronic pancreatitis — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Autosomal dominant hereditary chronic pancreatitis (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adolescent, Childhood
- Prevalence
- 1-9 / 1 000 000 (France)
Similar variants
- PRSS1 p.Arg116Cys Pathogenic/Likely pathogenic ★★ same residue
- PRSS1 p.Arg116His Uncertain significance ★★ ⚠ same residue
- PRSS1 p.Arg116Ser Uncertain significance ★ ⚠ same residue
- PRSS1 p.Arg116= Likely benign ★ same residue
- PRSS1 p.Ala16Val Pathogenic/Likely pathogenic ★★ ⚠ same condition
- PRSS1 p.Arg122Cys Pathogenic ★★ same condition
- PRSS1 p.Arg122His Pathogenic/Likely pathogenic ★★ ⚠ same condition
- PRSS1 p.Asn29Ile Pathogenic ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/prss1-p-arg116pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown